Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion type Assertion NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_head.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion wasGeneratedBy ECO_0000203 NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_provenance.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion wasDerivedFrom befree-20150227 NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_provenance.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion SIO_000772 12237899 NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_provenance.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion evidence source_evidence_literature NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_provenance.
- NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_assertion description "[In the latter case, h-R3 treatment (0.25-1 mg/mouse; every other day per 2 weeks) not only significantly reduced VEGF mRNA expression of A431 tumors growing subcutaneously in SCID mice but also resulted in reduction of the overall microvascular density (MVD), disappearance of dilated 'mother vessels,' as well as in suppression of tumor growth followed by regression of established tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771250.RA-zDz-HHLwvOhC-k8ih--XIJ1YwUUumHMDCjqqM5olk0130_provenance.